NCCTG

AcronymDefinition
NCCTGNorth Central Cancer Treatment Group
NCCTGNational Coordinating Committee on Therapeutic Goods (est. 1971; Australia)
References in periodicals archive ?
3] Nonstandard abbreviations: HER2, human growth factor receptor 2; IHC, immunohistochemistry; FISH, fluorescence in situ hybridization; FDA, US Food and Drug Administration; NCCTG, North Central Cancer Treatment Group; NSABP, National Surgical Adjuvant Breast and Bowel Project; CEP17, chromosome 17 centromere enumerating probe.
The NCCTG was founded in 1977 on the premise that the community practice setting, where most cancer care occurs, is the most appropriate venue for conducting clinical trials.
In the NCCTG trial, the delay between the completion of AC chemotherapy appeared to reduce the frequency of cardiac dysfunction.
The tumor samples examined in the study came from NCCTG N9831, a phase III randomized, multicenter clinical trial that tested adjuvant Herceptin given with, or following, chemotherapy with paclitaxel, compared with chemotherapy alone.
Furthermore, in the adjuvant setting, frequency of CNS metastasis as the first site of relapse was numerically greater in the trastuzumab arms in the HERA, NSABP B-31 and NCCTG N9831 trials [32,33].
3] NCCTG N9831 (US), NSABP B-31 (US), HERA - HERceptin Adjuvant (international), BCIRG 006 (international)
The NCCTG study enrolled its first patient in June 2000 and has enrolled 3,406 patients; the NSABP study began enrolment in March 2000 and has enrolled 2,085 patients.
Tumor SPARC microenvironment signature (SMS) and plasma levels in a phase II trial of unresectable stage IV melanoma treated with nab-paclitaxel and carboplatin: a translational study of NCCTG trial N057E (Abstract #8578)
As some of the clinical trials on Herceptin (such as NSABP B-31, BCIRG 006, NCCTG 9831) mature, some of these pivotal validation studies can be completed.
The NCCTG study enrolled its first patient in June 2000 and has enrolled 3,406 patients to date; the NSABP study began enrolment in March 2000 and has enrolled 2,085 patients to date.
Focal HER2/neu amplified clones partially account for discordance between immunohistochemistry and fluorescence in situ hybridization results: data from NCCTG N9831 intergroup adjuvant trial.
NCCTG N0937: Platinum chemotherapy (Cisplatin) and brostacillin for metastatic triple-negative breast cancer